Home
>
National Drug Code (NDC)
>
Lovastatin
Lovastatin - 0179-1435-30 - (Lovastatin)
Drug Information of Lovastatin
| Product NDC: | 0179-1435 |
| Proprietary Name: | Lovastatin |
| Non Proprietary Name: | Lovastatin |
| Active Ingredient(s): | 40 mg/1 & nbsp; Lovastatin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lovastatin
| Product NDC: | 0179-1435 |
| Labeler Name: | KAISER FOUNDATION HOSPITALS |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075636 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110718 |
Package Information of Lovastatin
| Package NDC: | 0179-1435-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (0179-1435-30) |
NDC Information of Lovastatin
| NDC Code | 0179-1435-30 |
| Proprietary Name | Lovastatin |
| Package Description | 30 TABLET in 1 BOTTLE (0179-1435-30) |
| Product NDC | 0179-1435 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lovastatin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110718 |
| Marketing Category Name | ANDA |
| Labeler Name | KAISER FOUNDATION HOSPITALS |
| Substance Name | LOVASTATIN |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
